(Q33252356)

English

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Eduardo Nobile-Orazio

object named as

E Nobile-Orazio

4

0 references

European Federation of Neurological Societies

1

object named as

European Federation of Neurological Societies

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

author name string

Peripheral Nerve Society

2

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

R D M Hadden

3

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

C Sommer

5

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

A Hahn

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

I Illa

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

E Morra

8

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

J Pollard

9

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

R A C Hughes

10

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

P Bouche

11

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

D Cornblath

12

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

E Evers

13

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

C L Koski

14

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

J M Léger

15

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

P Van den Bergh

16

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

P van Doorn

17

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

I N van Schaik

18

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

809-818

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Developing diagnostic criteria in Waldenstrom's macroglobulinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Distal acquired demyelinating symmetric neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

POEMS syndrome: definitions and long-term outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Uncompacted myelin lamellae in peripheral nerve biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Neurolymphomatosis: a clinicopathologic syndrome re-emerges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Cladribine in the treatment of IgM paraproteinemic polyneuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Patterns of nerve conduction abnormalities in POEMS syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01467.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2006.01467.X

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33252356&oldid=1537011127"